Elizabeth Garner's most recent trade in Kezar Life Sciences Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 17,793 | 0 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 17,793 | 17,793 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 8,896 | 0 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 8,896 | 8,896 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,000 | 26,000 | - | - | Stock Option (right to buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
Kezar Life Sciences Inc | Elizabeth Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 8,896 | 8,896 | - | - | Stock Option (Right to Buy) |